highperformr logo

Cynata Therapeutics's Overview

Total employees10
HeadquartersCremorne
Founded

Cynata Therapeutics Limited (ASX: CYP) is an Australian clinical-stage stem cell and regenerative medicine company focused on developing and commercialising a proprietary therapeutic stem cell platform technology, Cymerus™. This platform utilises induced pluripotent stem cells (iPSCs) and a precursor cell, mesenchymoangioblast (MCA), to achieve scalable and consistent manufacturing of mesenchymal stem cells (MSCs). Cynata's technology aims to address the critical issues of scale, batch-to-batch consistency, and manufacturing costs that have historically hindered the broader adoption of MSC therapies. Their lead product candidate, CYP-001, has been investigated for treating steroid-resistant acute graft-versus-host disease (GvHD), and the company is exploring other therapeutic areas including osteoarthritis, critical limb ischemia, and respiratory distress.

Where is Cynata Therapeutics's Headquarters?

HQ Function

Serves as the central hub for corporate administration, research and development oversight, clinical trial management, and strategic business development.

Notable Features:

Located in a modern commercial building within a precinct known for innovation, providing a contemporary and collaborative workspace.

Work Culture:

The work culture at Cynata's HQ is likely characterized by scientific rigor, innovation, collaboration, and a strong focus on achieving clinical milestones and advancing regenerative medicine.

HQ Significance:

The Melbourne headquarters places Cynata within Australia's prominent biomedical research ecosystem, facilitating access to talent, research institutions, and clinical trial sites.

Values Reflected in HQ: The headquarters' location and modern setup likely reflect Cynata's values of innovation, cutting-edge science, and a forward-thinking approach to therapeutic development.

Location:

While headquartered in Australia, Cynata Therapeutics maintains a global outlook for its clinical development and commercialisation strategies. They collaborate with international research institutions, contract manufacturing organizations (CMOs), and contract research organizations (CROs). Their clinical trials often involve sites in multiple countries, and they engage with regulatory authorities such as the FDA (USA) and EMA (Europe) for their product candidates. Strategic partnerships, like the one with Fujifilm for GvHD, extend their operational reach, particularly in markets like Japan.

Street Address:

Level 3, 100 Cubitt Street

City:

Cremorne

State/Province:

Victoria

Country:

Australia

Cynata Therapeutics's Global Presence

Buying Intent Signals for Cynata Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cynata Therapeutics

As of April 2025, Cynata Therapeutics' leadership includes:

Dr. Ross Macdonald - Chief Executive Officer & Managing Director
Dr. Kilian Kelly - Chief Operating Officer
Mr. Brendan Moore - Chief Financial Officer & Company Secretary
Dr. Jolanta Wodzinska - Vice President, Product Development

Investors of Cynata Therapeutics

Cynata Therapeutics has been backed by several prominent investors over the years, including:

Fidelity International (FIL Limited)
BioScience Managers
Sumitomo Pharma Co., Ltd. (via historical strategic alliance and investment)
Various institutional and retail shareholders (as an ASX-listed company)

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits0

Cynata Therapeutics has strengthened its executive team with a new COO and seen changes in Board leadership over the past year, positioning the company for further clinical and corporate development.

New Appointments:

Dr. Kilian Kelly, Dr. Kilian Kelly appointed as Chief Operating Officer to drive operational excellence and advance clinical programs.
Dr. Darryl Maher, Dr. Darryl Maher appointed as Non-Executive Chairman, bringing significant industry and leadership experience.

Technology (Tech Stack) used by Cynata Therapeutics

Discover the tools Cynata Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cynata Therapeutics Email Formats and Examples

Cynata Therapeutics likely utilizes common corporate email formats. The most probable patterns are [first_initial][last]@cynata.com or [first].[last]@cynata.com.

flast@cynata.com (e.g., jdoe@cynata.com) or first.last@cynata.com (e.g. jane.doe@cynata.com)

Format

rmacdonald@cynata.com

Example

80%

Success rate

News and media

Proactive Investors2024-05-20

Cynata Therapeutics encouraged by positive osteoarthritis trial results

Cynata Therapeutics reported positive final data from its Phase 1 clinical trial of CYP-001 in patients with osteoarthritis (OA), showing safety and efficacy signals....more

Cynata Therapeutics ASX Announcement2024-03-26

Cynata Receives FDA Clearance for Phase 2 DFU Clinical Trial

Cynata Therapeutics announced it received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to proceed with its Phase 2 clinical trial of Cymerus™ MSCs in patients with diabetic foot ulcers (DFU)....more

Cynata Therapeutics ASX Announcement2023-12-04

Cynata Appoints Dr Darryl Maher as Chairman

Cynata Therapeutics announced the appointment of Dr. Darryl Maher as Non-Executive Chairman, effective immediately. Dr. Maher brings extensive experience in the biotechnology and pharmaceutical industries....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cynata Therapeutics, are just a search away.